effects [qlco]
Low dose [qnco]
17 beta-Estradiol [horm, phsu, strd]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
tibolone [phsu, strd]
Fasting [fndg]
Plasma homocystine level [lbpr]
postmenopausal [tmco]
Women [popg]
postmenopausal [tmco]
Women [popg]
Currently [tmco]
Receive [qlco]
Hormone replacement therapy [topp]
Low dose [qnco]
17beta estradiol [horm, phsu, strd]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
tibolone [phsu, strd]
Hormone replacement therapy [topp]
Uncommon [qlco]
postmenopausal [tmco]
Women [popg]
homocysteine [aapp, bacs]
Known [qlco]
Independent [idcn]
Cardiovascular disease [dsyn]
Increased [qnco]
Levels [qlco]
Post-Menopause [orgf]
Study [mnob]
Compared [acty]
effects [qlco]
Low dose [qnco]
17beta estradiol [horm, phsu, strd]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
tibolone [phsu, strd]
Fasting [fndg]
Plasma homocysteine level [lbpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
N NOS [aapp, imft]
Study [mnob]
Women [popg]
Assigned [ftcn]
Received [qlco]
mg% [qnco]
Estradiol 0.5 MG [clnd]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
tibolone [phsu, strd]
weeks [tmco]
Fasting [fndg]
Plasma homocystine level [lbpr]
Measured [qlco]
baseline [bodm]
4th [qnco]
therapy [ftcn]
4th [qnco]
Plasma homocystine level [lbpr]
Group [idcn]
P NOS [aapp, imft]
End [spco]
Plasma homocystine level [lbpr]
Reduced [qlco]
Group [idcn]
P NOS [aapp, imft]
Low dose [qnco]
17beta estradiol [horm, phsu, strd]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
tibolone [phsu, strd]
Fasting [fndg]
Plasma homocystine level [lbpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
